Bopindolol

Bopindolol

Bopindolol is a beta blocker used in the treatment of hypertension. It is a non-selective beta blocker, meaning it blocks both β1 and β2 adrenergic receptors. Bopindolol is also a partial agonist, which means it not only blocks adrenergic receptors, but also has the ability to partially activate them.

Pharmacology

Bopindolol belongs to the class of beta blockers, which are medications primarily used to manage abnormal heart rhythms, and to protect the heart from a second heart attack (myocardial infarction) after a first heart attack (secondary prevention). They are also widely used to treat hypertension, although they are no longer the first choice for initial treatment of high blood pressure in many guidelines.

Bopindolol is a non-selective beta blocker, which means it blocks both β1 and β2 adrenergic receptors. β1-adrenergic receptors are located mainly in the heart and in the kidneys. β2-adrenergic receptors are located mainly in the lungs, gastrointestinal tract, liver, uterus, vascular smooth muscle, and skeletal muscle.

As a partial agonist, bopindolol not only blocks adrenergic receptors, but also has the ability to partially activate them. This can result in a more balanced and controlled response in the body.

Clinical Use

Bopindolol is used in the treatment of hypertension. Hypertension, also known as high blood pressure, is a long-term medical condition in which the blood pressure in the arteries is persistently elevated. Long-term high blood pressure is a major risk factor for coronary artery disease, stroke, heart failure, peripheral vascular disease, vision loss, and chronic kidney disease.

Side Effects

Like other beta blockers, bopindolol can cause a range of side effects. These can include fatigue, cold hands and feet, slow heartbeat, and gastrointestinal problems such as nausea, vomiting, and diarrhea. More serious side effects can include heart failure, severe allergic reactions, and bronchospasm.

See Also

• Beta blocker
• Hypertension
• Adrenergic receptor

‎